With so many blue chip ASX 200 shares for investors to choose from, it can be hard to decide which ones to buy.

To help narrow things down, I have picked out two that analysts rate as buys right now. They are as follows:

CSL Limited (ASX: CSL)

The first blue chip ASX 200 share that is highly rated is CSL. It is one of the world’s leading biotechnology companies, comprising the CSL Behring, CSL Vifor, and Seqirus businesses.

CSL has been growing its earnings at a solid rate for years thanks to a combination of strong demand for its products and its material investment in research and development (R&D) each year. The latter ensures that the company’s pipeline is filled to the brim with potential lifesaving and lucrative products.

Looking ahead, CSL has been tipped to continue its growth long into the future thanks to these same factors. In addition, this will be supported by improvements in plasma collections and the company’s new collection technology.

Citi is positive on CSL and currently has a buy rating and $350.00 price target on its shares.

Goodman Group (ASX: GMG)

Another blue chip ASX 200 share to look at is Goodman Group.

This leading integrated commercial and industrial property company currently has $77.8 billion of total assets under management and over 1,700 customers globally. This includes the likes of Amazon, Coles Group Ltd (ASX: COL), DHL, and Walmart.

But management isn’t settling for that. Goodman continues to build new properties and has $13.8 billion of development work in progress across 85 projects. With a yield on cost of 6.1%, these properties look likely to support its growth in the future.

UBS is a big fan of Goodman. It is expecting the company to continue its strong earnings growth in the coming years. As a result, it recently reiterated its buy rating with a $23.00 price target on its shares.

The post Here’s why analysts rate these strong blue chip ASX 200 shares as buys appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• The CSL share price is a sleeping dividend giant. Here’s why
• Strengthen your ASX portfolio with these blue chip blockbusters: analysts
• Which stocks does Warren Buffett own (and what can ASX 200 investors learn from this)?
• CSL shares dip despite new FDA approval
• What are analysts saying about the CSL share price?

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/JRi9UHW

• Stock Market